We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Overrules EMA Rejection of Orphan Liver Treatment Orphacol
Court Overrules EMA Rejection of Orphan Liver Treatment Orphacol
August 9, 2013
A European court has overturned the European Medicines Agency’s refusal to grant marketing authorization for a drug to treat rare liver diseases, saying the safety and effectiveness of the active ingredient have been well-established for over 10 years.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor